The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 5, 1997, Pages 655-658

  Shadkhan, Y ^a   Segal, E ^a   Bor, A ^a   Gov, Y ^a   Rubin, M ^a   Lichtenberg, D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; INTRALIPID; LIPID EMULSION;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; DRUG STABILITY; EMULSION; HEMOLYSIS; MINIMUM INHIBITORY CONCENTRATION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; EMULSIONS; HUMANS; LIPIDS; MICROBIAL SENSITIVITY TESTS;

EID: 0030927371     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.5.655     Document Type: Article

References (10)

1. Perfect, J. R., Pickard, W. W., Hunt, D. L., Palmer, B. & Schell, W. A. (1991). The use of amphotericin B In nosocomial fungal infection. Reviews of Infectious Diseases 13, 474-9.
2. Burgess, J. L. & Birchall, R. (1972). Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function. American Journal of Medicine 53, 77-84.
3. Brajtburg, J., Elberg, S., Kobayashi, G. S. & Medoff, G. (1990). Inhibition of amphotericin B (Fungizone) toxicity to cells by egg lecithin-glycocholic acid mixed micelles. Antimicrobial Agents and Chemotherapy 34, 2415-6.
4. Hiemenz, J. W. & Walsh, T. J. (1996). Lipid formulation of amphotericin B: recent progress and future directions. Clinical Infectious Diseases 22, Suppl. 2, S133-44.
5. Kirsh, R., Goldstein, R., Tarloff, J., Parris, D., Hook, J., Hanna, N. et al. (1988). An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. Journal of Infectious Diseases 158, 1065-70.
6. Caillot, D., Casasnovas, O., Solary, E., Chavanet, P., Bonnotte, B., Reny, G. et al. (1993). Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients. Journal of Antimicrobial Chemotherapy 31, 161-9.
7. Washington, C., Lance, M. & Davis, S. S. (1993). Toxicity of amphotericin B emulsion formulations. Journal of Antimicrobial Chemotherapy 31, 806-8.
8. Rotenberg, M., Rubin, M., Bor, A., Meyuhas, D., Talmon, Y. & Lichtenberg, D. (1991). Physico-chemical characterization of Intralipid emulsions. Biochimica et Biophysica Acta 1086, 265-72.
9. Shadomy, S. & Pfaller, M. A. (1991). Laboratory studies with antifungal agents: susceptibility tests and quantitation in body fluids. In Manual of Clinical Microbiology, 5th edn (Balows, A., Hausler, W. J., Herrmann, K. L., Isenberg, H. D. & Shadomy, H. J., Eds), pp. 1173-83. American Society for Microbiology, Washington, DC.
10. Souza, L. C., Maranhao, R. C., Schreier, S. & Campa, A. (1993). In-vitro and in-vivo studies of the decrease of amphotericin B toxicity upon association with a triglyceride-rich emulsion. Journal of Antimicrobial Chemotherapy 32, 123-32.